[1]
|
E. Gruys, M. J. M. Toussaint, W. J. M. Landman, M. Tivapasi, R. Chamanza and L. Van Veen, “Infection, Inflammation and Stress Inhibit Growth. Mechanisms and Non-Specific Assessment of the Processes by Acute Phase Proteins,” In: T. Wensing, Ed., Production Diseases in Farm Animals, Wageningen Press, Wageningen, 1999, pp. 72-87.
|
[2]
|
P. D. Eckersall, “Recent Advances and Future Prospects for the Use of Acute Phase Proteins as Markers of Disease in Animals,” Revue de Medicine Veterinary, Vol. 151, No. 7, 2000, pp. 577-578.
|
[3]
|
J. J. Ceron, P. D. Eckersall and S. Martynez-Subiela, “Acute Phase Proteins in Dogs and Cats: Current Knowledge and Future Perspectives,” Veterinary Clinical Pathology, Vol. 34, No. 2, 2005, pp. 85-99.
doi:10.1111/j.1939-165X.2005.tb00019.x
|
[4]
|
M. V. Crisman, W. K. Scarratt and K. L. Zimmerman, “Blood Proteins and Inflamationin the Horse,” Veterinary Clinics of North America: Equine Practice, Vol. 24, No. 2, 2008, pp. 285-297. doi:10.1016/j.cveq.2008.03.004
|
[5]
|
S. Casella, F. Fazio, C. Giannetto, E. Giudice and G. Piccione, “Influence of Transportation on Serum Concentrations of Acute Phase Proteins in Horse,” Research Veterinary Science, Vol. 93, No. 2, 2012, pp. 914-917.
doi:10.1016/j.rvsc.2012.01.004
|
[6]
|
A. Cywinska, R. Gorecka, E. Szarska, L. Witkowki, P. Dziekan and A. Scholienberger, “Serum Amyloid A Level as a Potential Indicator of the Status of Endurance Horses,” Equine Veterinary Journal, Vol. 42, No. S38, 2010, pp. 23-27. doi:10.1111/j.2042-3306.2010.00280.x
|
[7]
|
A. Cywińska, E. Szarska, R. Górecka, L. Witkowski, M. Hecold, A. Bereznowski, A. Schollenberger and A. Winnicka, “Acute Phase Protein Concentrations after Limited Distance and Long Distance Endurance Rides in Horses,” Research Veterinary Science, Vol. 93, No. 3, 2012, pp. 1402-1406. doi:10.1016/j.rvsc.2012.02.008
|
[8]
|
J. Kent, “Acute Phase Proteins: Their Use in Veterinary Diagnosis,” British Veterinary Journal, Vol. 148, No. 4, 1992, pp. 279-282. doi:10.1016/0007-1935(92)90081-B
|
[9]
|
D. Thompson, A. Mildford-Ward and J. Whicher, “The Value of Acute Phase Measurements in Clinical Practice,” Annals of Clinical Biochemistry, Vol. 29, No. 2, 1992, pp. 123-131.
|
[10]
|
I. Kushner and A. Mackiewicz, “The Acute Phase Response: An Overview,” In: A. Mackiewicz, I. Kushner, H. Baumann, Eds., Acute Phase Proteins Molecular Biology, Biochemistry and Clinical Applications, CRC Press, Boca Ratón, 1993, pp. 3-19.
|
[11]
|
A. Hillstr?m, H. Tvedten and I. Lilieh??k, “Evaluation of an In-Clinic Serum Amyloid A (SAA) Assay and Assessment of the Effects of Storage on SAA Samples,” Acta Veterinaria Scandinavica, Vol. 2, No. 1, 2010, pp. 52-58.
|
[12]
|
C. Gabay and I. Kushner, “Acute Phase Proteins and Other Systemic Responses to Inflammation,” New England Journal of Medicine, Vol. 340, 1999, pp. 448-454.
doi:10.1056/NEJM199902113400607
|
[13]
|
S. Jacobsen and P. H. Andersen, “The Acute Phase Protein Serum Amyloid A (SAA) as a Marker of Inflammation in Horses,” Scandinavian Journal of Immunology Vol. 19, No. 1, 2007, pp. 38-46.
|
[14]
|
A. Husebekk, G. Husby, K. Sletten, G. Marhaug and K. Nordstoga, “Characterization of Amyloid Protein AA and Its Serum Precursor SAA in the Horse,” Scandinavian Journal of Immunology, Vol. 23, No. 6, 1986, pp. 703- 709. doi:10.1111/j.1365-3083.1986.tb02007.x
|
[15]
|
Y. Nunokawa, T. Fujinaga, T. Taira, M. Okumura, K. Yamashita, N. Tsunoda and M. Hagio, “Evaluation of Serum Amyloid A Protein as an Acute-Phase Reactive Protein in Horses,” Journal of Veterinary Medical Science, Vol. 55, No. 6, 1993, pp. 1011-1016.
doi:10.1292/jvms.55.1011
|
[16]
|
K. Sletten, A. Husebekk and G. Husby, “The Primary Structure of Equine Serum Amyloid A (SAA) Protein,” Scandinavian Journal of Immunology, Vol. 30, No. 1, 1989, pp. 117-122.
doi:10.1111/j.1365-3083.1989.tb01195.x
|
[17]
|
C. Hultén, K. Sletten, C. F. Bruun and G. Marhaug, “The Acute Phase Serum Amyloid A Protein (SAA) in the Horse: Isolation and Characterization of Three Isoforms,” Veterinary Immunology Immunopathology, Vol. 57, No. 3-4, 1999, pp. 215-227.
doi:10.1016/S0165-2427(97)00021-4
|
[18]
|
S. Jacobsen, Th. A. Niewold, M. H. Thomsen, S. Nanni, C. Lindegaard, E. Olsen and P. H. Andersen, “Serum Amyloid A Isoforms in Serum and Synovial Fluid in Horses with Lipopolysaccharide-Induced Arthritis,” Veterinary Immunology Immunopathology, Vol. 112, No. 3-4, 2006, pp. 321-322. doi:10.1016/j.vetimm.2005.10.014
|
[19]
|
L. C. Berg, S. Jacobsen and P. D. Thomsen, “Local Production of Serum Amyloid A in Equine Articular Cartilage and Cultured Chondrocytes,” International Journal of Experimental Pathology, Vol. 88, No. 4, 2007, pp. 58- 59.
|
[20]
|
L. C. Berg, P. D. Thomsen, P. H. Andersen, H. E. Jensen and S. Jacobsen, “Serum Amyloid A Is Expressed in Histologically Normal Tissues from Horses and Cattle,” Veterinary Immunology and Immunopathology, Vol. 144, No. 1-2, 2011, pp. 155-159.
doi:10.1016/j.vetimm.2011.06.037
|
[21]
|
T. L. McDonald, M. A. Larson, D. R. Mack and A. Weber, “Elevated Extrahepatic Expression and Secretion of Mammary-Associated Serum Amyloid A 3 (M-SAA3) into Colostrum,” Veterinary Immunology Immunopathology, Vol. 83, No. 3-4, 2001, pp. 203-211.
doi:10.1016/S0165-2427(01)00380-4
|
[22]
|
S. Jacobsen, M. H. Thomsen and S. Nanni, “Concentrations of Serum Amyloid A in Serum and Synovial Fluid from Healthy Horses and Horses with Joint Disease,” American Journal of Veterinary Research, Vol. 67, No. 10, 2006, pp. 1738-1742. doi:10.2460/ajvr.67.10.1738
|
[23]
|
C. Hultén, R. M. Tulamo, M. M. Suominem, K. Burwall, G. Marhaug and M. Forsberg, “A Non-Competitive Chemiluminescence Enzyme Immunoassay for the Equine Acute Phase Protein Serum Amyloid A (SAA)—A Clinically Useful Inflammatory Marker in the Horse,” Veterinary Immunology Immunopathology, Vol. 68, No. 2-4, 1999, pp. 267-281. doi:10.1016/S0165-2427(99)00027-6
|
[24]
|
S. J. Stoneham, L. Palmer, R. Cash and P. D. Rossdale, “Measurement of Serum Amyloid A in the Neonatal Foal Using a Latex Agglutination Immunoturbidimetic Assay: Determination of the Normal Range, Variation with Age and Response to Disease,” Equine Veterinary Journal, Vol. 33, 2001, pp. 559-603.
|
[25]
|
K. Satué and A. Calvo, “Normal Values of Serum Amyloid A, Haptoglobin and C-Reactive Protein in Spanish Purebred Mares during Estrous Cycle,” Proceeding of the 16th Italian Association of Equine Veterinarians Congress, Carrara, 29-31 January 2010, p. 263.
|
[26]
|
K. Satué, A. Calvo and P. Montesinos, “Normal Values of Serum Amyloid A, Haptoglobin and C-Reactive Protein in Spanish Purebred Mares during Pregnancy,” Proceeding of the 12th International Congress of European College of Veterinary Internal Medicine, Dublin, 1-3 September 2010, p. 549.
|
[27]
|
K. Satué, A. Calvo and J. J. Cerón, “Proteínas de Fase Aguda: Pueden ser Utilizadas Como Fuente de Diagnóstico de Gestación en la Yegua Pura Raza Espa?ola?” Proceeding of the 10th International Congress of Medicine and Surgery Equine, Sevilla, 27-28 November 2010, pp. 141-144.
|
[28]
|
C. Hultén, B. Sandgren, E. Ski?ldebrand, B. Kligeborn, G. Marhaug and M. Forsberg, “The Acute Phase Protein Serum Amyloid A (SAA) as an Inflammatory Marker in Equine Influenza Virus Infection,” Acta Veterinaria Scandinavica, Vol. 40, No. 4, 1999, pp. 323-333.
|
[29]
|
C. Hultén and S. Demmers, “Serum Amyloid A (SAA) as an Aid in the Management of Infectious Disease in the Foal: Comparison with Total Leucocyte Count, Neutrophil Count and Fibrinogen,” Equine Veterinary Journal, Vol. 34, No. 7, 2002, pp. 693-698.
doi:10.2746/042516402776250360
|
[30]
|
C. Hultén, U. Gr?nlund, J. Hirvonen, R. M. Tulamo, M. M. Suominem, G. Marhaug and M. Forsberg, “Dynamics in the Serum of the Inflammatory Markers Serum Amyloid A (SAA), Haptoglobin, Fibrinogen and ?2-Globulins during Induced Non-Infectious Arthritis in the Horse,” Equine Veterinary Journal, Vol. 34, No. 7, 2002, pp. 669- 704.
|
[31]
|
S. Jacobsen, J. C. Jensen, S. Frei, A. L. Jensen and M. B. Thoefner, “Use of Serum Amyloid A and Other Acute Phase Reactants to Monitor the Inflammatory Response after Castration in Horses: A Field Study,” Equine Veterinary Journal, Vol. 37, No. 6, 2005, pp. 552-556.
doi:10.2746/042516405775314853
|
[32]
|
S. Jacobsen, J. V. Nielsen, M. Kjelgaard-Hansen, T. Toelboell and J. Fjeldborg, “Acute Phase Response to Surgery of Varying Intensity in Horses: A Preliminary Study,” Veterinary Surgery, Vol. 38, No. 6, 2009, pp. 762-769.
doi:10.1111/j.1532-950X.2009.00564.x
|
[33]
|
P. J. Pollock, M. Prendergast, J. Schumacher and C. R. Bellenger, “Effects of Surgery on the Acute Response in Clinically Normal and Diseased Horses,” Veterinary Record, Vol. 156, No. 17, 2005, pp. 538-542.
|
[34]
|
M. B. Pepys, M. L. Baltz and G. A. Tennent, “Serum Amyloid A protein (SAA) in Horses: Objective Measurement of the Acute Phase Response,” Equine Veterinary Journal, Vol. 21, No. 2, 1989, pp. 106-109.
doi:10.1111/j.2042-3306.1989.tb02108.x
|
[35]
|
M. Christensen, S. Jacobsen, T. Ichiyanagi and M. Kjelgaard-Hansen, “Evaluation of an Automated Assay Base Don Monoclonal Anti-Human Serum Amyloid A (SAA) Antibodies for Measurement of Canine, Feline and Equine SAA,” Veterinary Journal, Vol. 194, No. 3, 2012, pp. 332-337. doi:10.1016/j.tvjl.2012.05.007
|
[36]
|
M. Satoh, T. Fujinaga, M. Okumura and M. Hagio, “Sándwich Enzyme-Linked Immunosorbent Assay for Quantitative Measurement of Serum Amyloid A Protein in Horses,” American Journal of Veterinary Research, Vol. 56, Vol. 10, 1995, pp. 1286-1291.
|
[37]
|
V. Duggan, G. R. Holyoak, C. G. Mac Allister and A. W. Confer, “Influence of Induction of Parturition on the Neonatal Acute Phase Response in Foals,” Theriogenology, Vol. 67, No. 2, 2007, pp. 372-381.
doi:10.1016/j.theriogenology.2006.06.015
|
[38]
|
S. Paltrinieri, “The Feline Acute Phase Reaction,” Veterinary Journal, Vol. 177, No. 1, 2008, pp. 26-35.
doi:10.1016/j.tvjl.2007.06.005
|
[39]
|
E. Harada, Y. Araki, E. Furumura, T. Takeuchi, K. Sitizyo, T. Yajima and T. Kuwata, “Characteristic Transfer of Colostrum-Derived Biologically Active Substances into Cerebrospinal Fluid via Blood in Natural Suckling Neonatal Pigs,” Journal of Veterinary Medicine A Physiology, Pathology, Clinical Medicine, Vol. 49, No. 7, 2002, pp. 358-364. doi:10.1046/j.1439-0442.2002.00457.x
|
[40]
|
P. M. Chavatte, M. B. Pepys, B. Roberts, J. C. Ousey, A. J. McGladdery and P. D. Rossdale, “Measurement of Serum Amyloid A protein (SAA) as an Aid to Differential Diagnosis of Infection in Newborn Foals,” In: W. Plowright, P. D. Rossdale, J. F. Wade and J. F. Eds., Equine Infectious Diseases 6, Proceedings of the 6th International Conference, R&W Publications, Newmarket, 1992, pp. 33-38.
|
[41]
|
C. J. Rosenthal and E. C. Franklin, “Variation with Age and Disease of an Amyloid A Protein-Related Serum Component,” Journal of Clinical Investigation, Vol. 55, No. 4, 1975, pp. 746-753. doi:10.1172/JCI107985
|
[42]
|
M. Chistoffersen, C. Baagore, S. Jacobsen, A. M. Bojesen, M. R. Petersen and H. Lehn-Jensen, “Evaluation of the Systemic Acute Phase Response and Endometrial Gene Expression of Serum Amyloid A and Pro- and Anti-Inflammatory Cytokines in Mares with Experimentally Induced Endometritis,” Veterinary Immunology and Immunopathology, Vol. 138, No. 1-2, 2010, pp. 95-105.
doi:10.1016/j.vetimm.2010.07.011
|
[43]
|
M. Christoffersen, E. Woodward, A. M. Bojesen, S. Jacobsen, M. R. Petersen, M. H. Troedsson and H. Lehn-Jensen, “Inflammatory Responses to Induced Infectious Endometritis in Mares Resistant or Susceptible to Persistent Endometritis,” BMC Veterinary Research, Vol. 29, No. 8, 2012, p. 41. doi:10.1186/1746-6148-8-41
|
[44]
|
R. Dabrowski, K. Kostro, U. Lisiecka, M. Szczubia? and L. Krakowski, “Usefulness of C-Reactive Protein, Serum Amyloid A Component, and Haptoglobin Determinations in Bitches with Pyometra for Monitoring Early Post- Ovariohysterectomy Complications,” Theriogenology, Vol. 72, No. 4, 2009, pp. 471-476.
doi:10.1016/j.theriogenology.2009.03.017
|
[45]
|
F. Tecles, M. Caldín, A. Zanella, F. Membiela, A. Tvarijonaviciute, S. Martínez Subiela and J. J. Cerón, “Serum Acute Phase Protein Concentrations in Female Dogs with Mammary Tumors,” Journal of Veterinary Diagnostic Investigation, Vol. 21, No. 2, 2009, pp. 214-219.
doi:10.1177/104063870902100206
|
[46]
|
L. Krakowski, C. H. Krawcyk, K. Kostro, T. Stefaniak, F. Novotry and J. Obara, “Serum Levels of Acute Phase Proteins: SAA, Hp and Progesterone (P4) in Mares with Early Embryonic Death,” Reproduction in Domestic Animals, Vol. 46, No. 4, 2011, pp. 624-629.
doi:10.1111/j.1439-0531.2010.01715.x
|
[47]
|
V. Duggan, “Serum Amyloid A in the Neonatal Foal: The Significance of Peri-Parturient Events,” Veterinary Journal, Vol. 176, No. 3, 2008, pp. 267-269.
doi:10.1016/j.tvjl.2007.08.029
|
[48]
|
M. A. Larson, S. H. Wei, A. Weber, A. T. Weber and T. L. McDonald, “Induction of Human Mammary-Associated Serum Amyloid A3 Expression by Prolactin or Lipopolysaccharide,” Biochemical and Biophysical Research Communications, Vol. 301, No. 4, 2003, pp. 1030-1037.
doi:10.1016/S0006-291X(03)00045-7
|
[49]
|
D. R. Mack, T. L. McDonald, M. A. Larson, S. Wei and A. Weber, “The Conserved TFLK Motif of Mammary- Associated Serum Amyloid A3 Is Responsible for Up- Regulation of Intestinal MUC3 Mucin Expression in Vitro,” Pediatric Research, Vol. 53, 2003, pp. 137-142.
doi:10.1203/00006450-200301000-00023
|
[50]
|
A. J. Molenaar, D. P. Harris, G. H. Rajan, M. L. Pearson, M. R. Callaghan, L. Sommer, V. C. Farr, K. E. Oden, M. C. Miles, R. S. Petrova, L. L. Good, K. Singh, R. D. McLaren, C. G. Prosser, K. S. Kim, R. J. Wieliczko, M. H. Dines, K. M. Johannessen, M. R. Grigor, S. R. Davis and K. Stelwagen, “The Acute-Phase Protein Serum Amyloid A3 Is Expressed in the Bovine Mammary Gland and Plays a Role in Host Defense,” Biomarkers, Vol. 14, No. 1, 2009, pp. 26-37. doi:10.1080/13547500902730714
|
[51]
|
K. Baintner and J. Csapó, “Lack of Acid-Resistant Trypsin Inhibitor in Mare’s Colostrum: Short Communication,” Acta Veterinaria Hungarica, Vol. 44, No. 1, 1996, pp. 95-97.
|
[52]
|
G. P. Sacks, K. Studena, I. L. Sargent and W. G. Redman, “Normal Pregnancy and Pre-Clampsia Both Produce Inflammatory Changes in Peripheral Blood Leukocytes Akin to Those of Sepsis,” American Journal of Obstetrics & Gynecology, Vol. 179, No. 1, 1988, pp. 80-86.
doi:10.1016/S0002-9378(98)70254-6
|
[53]
|
M. D. Savvidou, C. C. Lees, M. Parra, A. D. Hingorani and K. H. Nicolaides, “Levels of C-Reactive Protein in Pregnant Women Who Subsequently Develop Pre-Clampsia,” BJOG, Vol. 109, No. 3, 2002, pp. 297-301.
doi:10.1111/j.1471-0528.2002.01130.x
|
[54]
|
A. F. Sanchez Teran, L. M. Rubio-Martinez, N. F. Villarino and M. G. Sanz, “Effects of Repeated Intra-Articular Administration of Amikacin on Serum Amyloid A, Total Protein and Nucleated Cell Count in Sinovial Fluid from Healthy Horses,” Equine Veterinary Journal, Vol. 44, No. S43, 2012, pp. 12-16.
doi:10.1111/j.2042-3306.2012.00637.x
|
[55]
|
M. Henriksen, S. Jacobsen and P. H. Andersen, “Serum Amyloid A (SAA) in Equine Serum and Vitreous,” Veterinary Ophthalmology, Vol. 12, No. 1, 2009, pp. 6-7.
|
[56]
|
A. L. Labelle, R. E. Hamor, A. L. Macneill, K. M. Lascola, C. B. Breaux and E. L. Tolar, “Effects of Ophthalmic Disease on Concentrations of Plasma Fibrinogen and Serum Amyloid A in the Horse,” Equine Veterinary Journal, Vol. 43, No. 4, 2011, pp. 460-465.
doi:10.1111/j.2042-3306.2010.00305.x
|
[57]
|
K. Tsukada, S. Takenoshita and Y. Nagamachi, “Peritoneal Interleukin-6, Interleukin-8, and Granulocyte Elastase Activity after Elective Abdominal Surgery,” APMIS, Vol. 102, No. 7-12, 1994, pp. 837-840.
doi:10.1111/j.1699-0463.1994.tb05242.x
|
[58]
|
N. E. Robinson, “Recurrent Airway Obstruction (Heaves),” In: P. Lekeux, Ed., Equine Respiratory Diseases, International Veterinary Information Service, Ithaca, New York, 2001.
|
[59]
|
A. Lavoie-Lamoureux, M. Leclere, K. Lemos, B. Wagner and J. P. Lavoie, “Markers of Systemic Inflammation in Horses with Heaves,” Journal Veterinary Internal Medicine, Vol. 26, No. 6, 2012, pp. 1419-1426.
doi:10.1111/j.1939-1676.2012.00993.x
|
[60]
|
N. D. Cohen, M. K. Chaffin, M. L. Vandenplas, R. F. Edwards, M. Nevill, J. N. Moore and R. J. Martens, “Study of Serum Amyloid A Concentrations as a Means of Achieving Early Diagnosis of Rhodococcus equi Pneumonia,” Equine Veterinary Journal, Vol. 37, No. 3, 2005, pp. 212-216. doi:10.2746/0425164054530704
|
[61]
|
H. H. Petersen, J. P. Nielsen, C. Helweg and P. M. Heeg?rd, “Application of Acute Phase Protein Measurements in Veterinary Clinical Chemistry,” Veterinary Research, Vol. 35, No. 2, 2004, pp. 163-187.
doi:10.1051/vetres:2004002
|
[62]
|
S. A. Andersen, H. H. Petersen, A. K. Ersboll, J. Falk-Ronne, A. L. Jensen and S. Jacobsen, “Equine Serum Amyloid A Response Following Vaccination against Influenza and Tetanus,” Proceeding of International Colloquium on Acute Phase Proteins, Dublin, 14-15 March 2005, p. 36.
|
[63]
|
S. A. Andersen, H. H. Petersen, A. K. Ersboll, J. Falk- Ronne, A. L. Jensen and S. Jacobsen, “Vaccination Elicits a Prominent Acute Phase Response in Horses,” Veterinary Journal, Vol. 121, No. 2, 2012, pp. 199-202.
doi:10.1016/j.tvjl.2011.01.019
|
[64]
|
E. Wattrang, D. M. Jesset, P. Yates, L. Fuxler and D. Hannant, “Experimental Infection of Ponies with Equine Influenza A2 (H3N8) Virus Strains of Different Pathogenicity Elicits Varying Interferon and Interlukin-6 Responses,” Viral Immunology, Vol. 16, No. 1, 2003, pp. 57-67. doi:10.1089/088282403763635456
|
[65]
|
J. Danek, “Level of Interlukin-1β and Clinical Signs after Endotoxin Injection in Stallions,” Bulletin of the Veterinary Institute Pulawy, Vol. 46, 2002, pp. 179-185.
|
[66]
|
M. B. Pepys, “C-Reactive Protein Fifty Years on,” Lancet, Vol. 317, No. 8221, 1981, pp. 653-857.
doi:10.1016/S0140-6736(81)91565-8
|
[67]
|
J. T. Whicher and P. Dieppe, “Acute Phase Proteins,” Journal of Allergy and Clinical Immunology, Vol. 5, 1985, pp. 425-446.
|
[68]
|
G. Husby, “Equine Amyloidosis,” Equine Veterinary Journal, Vol. 20, No. 4, 1988, pp. 235-238.
doi:10.1111/j.2042-3306.1988.tb01510.x
|